Document is current

Article History

Accepted: 27 November 2023

First Online: 21 December 2023

Declarations

:

: This study was funded by UCB Pharma.

: This study was conducted under a research contract between UCB Pharma and RTI Health Solutions and was funded by UCB Pharma. Kerrie-Anne Ho, Meredin Stoltenberg, and Thais Tarancon are employees of UCB Pharma. Carol Mansfield and Anna Pierce are employees of RTI Health Solutions.

: Authors affiliated with the study sponsor, UCB Pharma, participated in the design and conduct of the study; analysis and interpretation of the data; preparation, review, and approval of the manuscript; and decision to submit the manuscript for publication.

: The RTI International Institutional Review Board reviewed the study protocol for this case study and confirmed it exempt from full review.

: All study participants provided informed consent.

: Not applicable.

: Not applicable.

: The datasets generated and/or analyzed during the current study are not publicly available.

: Concept and design: K-AH, CM. Analysis and interpretation of data: K-AH, AP, MS, TT, CM. Critical revision of paper for important intellectual content: K-AH, AP, MS, TT, CM. Statistical analysis: AP, CM. Provision of study materials or patients: AP, CM. Obtaining funding: K-AH. Supervision: K-AH, CM. All authors have read and approved the final article.